Info

Patients at risk PJP, Adult

  • HIV/AIDS patients with CD4 counts <200 cells/μL.
  • Solid organ and hematopoietic stem cell transplant recipients. In case-control study, post-transplant PJP  associated with active CMV, allograft rejection, and termination of prophylaxis: Clin infect Dis 2019;68:1320
  • Cancer chemotherapy patients, especially those on high-dose steroid therapy (≥ 20 mg of daily Prednisone, or the equivalent, for over a month).
  • Selected rheumatologic diseases that require ≥ 20 mg Prednisone (or the equivalent) on a daily basis.
  • Can present as a subacute infection with several days to weeks of symptoms, especially in HIV/AIDS.

參考➡️ Incidence of Pneumocystis jiroveci pneumonia among groups at risk in HIV-negative patients